Cargando…
Epigenetics provides a new generation of oncogenes and tumour-suppressor genes
Cancer is nowadays recognised as a genetic and epigenetic disease. Much effort has been devoted in the last 30 years to the elucidation of the ‘classical’ oncogenes and tumour-suppressor genes involved in malignant cell transformation. However, since the acceptance that major disruption of DNA methy...
Autor principal: | Esteller, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361113/ https://www.ncbi.nlm.nih.gov/pubmed/16404435 http://dx.doi.org/10.1038/sj.bjc.6602918 |
Ejemplares similares
-
ASPP: a new family of oncogenes and tumour suppressor genes
por: Sullivan, A, et al.
Publicado: (2007) -
Host epigenetic modifications by oncogenic viruses
por: Flanagan, J M
Publicado: (2007) -
Rab25 as a tumour suppressor in colon carcinogenesis
por: Goldenring, J R, et al.
Publicado: (2011) -
Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think
por: Lobry, Camille, et al.
Publicado: (2011) -
Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update
por: Llinàs-Arias, Pere, et al.
Publicado: (2017)